Vitamin C’s on-again, off-again reputation as a cancer fighter has a new twist: researchers now think that at very high doses it works in the opposite way to how it was long imagined.
Vitamin C is famous as an antioxidant. But at the extremely high concentrations reached only through intravenous delivery — especially around tumors — it can “flip roles” and act as a pro-oxidant, generating hydrogen peroxide. That reactive compound tends to damage cancer cells more than normal ones, because tumor cells are already metabolically stressed, grow fast, have poor blood supply and weaker internal cleanup systems.
What the evidence shows
The effect has been seen in lab studies and small human trials across various cancers. Patients given intravenous vitamin C alongside chemotherapy have reported less fatigue, pain and nausea — but whether it extends survival remains unproven, with mixed results.
The crucial caveats
Two points matter most. First, the doses required cannot be reached with tablets — only carefully controlled IV administration achieves them. Second, this remains experimental: it belongs in clinical trials or supervised medical settings, not commercial “wellness” clinics selling infusions. Vitamin C is not a proven cancer treatment.
This article explains ongoing research and is not medical advice. Do not use high-dose vitamin C to treat any condition without a qualified oncologist’s supervision.